Novo CEO signals M&A opportunities to strengthen drug pipeline | Blerbz

← Back to Feed

/Novo CEO signals M&A opportunities to strengthen drug pipeline

Novo CEO signals M&A opportunities to strengthen drug pipeline

September 22, 2026 at 09:00 AM

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

Read the full article on CNBC

Read Full Article →

Home News Feed BLERBZ100 About

© 2026 Blerbz. All rights reserved. | Privacy | Terms